Breast Milk Sugar 2'-FL Boosts Memory and Learning Through Gut Bacteria
Study shows 2'-fucosyllactose improves cognitive function in mice by modulating gut microbiota and brain serotonin levels.
20 articles
Study shows 2'-fucosyllactose improves cognitive function in mice by modulating gut microbiota and brain serotonin levels.
Biochemist Jessie InchauspΓ© reveals how maternal blood sugar, choline, protein and omega-3s shape baby's brain and metabolism.
Multi-omics study reveals how altered gut microbiome in autistic children produces specific proteins and metabolites that cross the blood-brain barrier.
New research reveals how glucose availability directs brain cell proliferation via a metabolic-epigenetic axis, with implications for MS and brain repair.
Scientists discover how brain cells signal distress before myelin damage, offering new targets for MS prevention.
Scientists discover harmful bacterial sugars in the gut trigger immune attacks that damage the brain in ALS and dementia patients.
HIE disrupts the glymphatic system in neonatal brains, impairing waste clearance and development with lasting consequences.
Dr. Justin Sonnenburg explains how fermented foods and fiber impact gut health, inflammation, and disease risk.
A 5-year cohort study finds elevated blood palmitoleic acid β a marker of excess energy intake β accelerates brain hypometabolism linked to cognitive decline.
Five large studies reveal dairy as the strongest dietary risk factor for Parkinson's disease, with potential brain cell damage mechanisms identified.
A 6,000+ organoid study links specific cellular phenotypes to microcephaly, polymicrogyria, epilepsy, and intellectual disability with 92% classification accuracy.
Simple compound successfully treats life-threatening COQ2 deficiency in newborn, offering hope for rare mitochondrial disorders.
A Cochrane review of two RCTs finds very low-certainty evidence that IGF-1 neither prevents nor worsens retinopathy of prematurity in extremely preterm infants.
Scientists identify a rogue immune cell population fueling multiple sclerosis progression β and a promising drug target to stop it.
Large Norwegian study reveals prenatal factors significantly influence MS risk, with maternal diabetes more than doubling offspring's chances.
New study shows L. acidophilus probiotic improves cognitive recovery after stroke by reprogramming brain immune cells through gut-brain pathway.
A multinational study finds 56% of genetically diagnosed infants with epilepsy have variants potentially amenable to antisense oligonucleotide treatment.
A comprehensive review details how NMOSD, MOGAD, and other rare CNS disorders are frequently mistaken for MS β and how to tell them apart.
A molecule called OLE restores microglia's protective function, reducing amyloid plaques and improving memory in animal models.
A landmark study links epigenetic patterns at birth to infant gut microbiome development, with certain bacteria reducing neurodevelopmental risk by age three.